New interleukin-15 superagonist (IL-15SA) significantly enhances graft-versus-tumor activity

Interleukin-15 (IL-15) is a potent cytokine that increases CD8(+) T and NK cell numbers and function in experimental models. However, obstacles remain in using IL-15 therapeutically, specifically its low potency and short in vivo half-life. To help overcome this, a new IL-15 superagonist complex com...

Descripción completa

Detalles Bibliográficos
Autores principales: Bailey, Cavan P., Budak-Alpdogan, Tulin, Sauter, Christopher T., Panis, Michelle M., Buyukgoz, Cihangir, Jeng, Emily K., Wong, Hing C., Flomenberg, Neal, Alpdogan, Onder
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5546486/
https://www.ncbi.nlm.nih.gov/pubmed/28574833
http://dx.doi.org/10.18632/oncotarget.17875

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5546486/
https://www.ncbi.nlm.nih.gov/pubmed/28574833
http://dx.doi.org/10.18632/oncotarget.17875

Ejemplares similares